Table 5. Univariate analysis of distant recurrence-free survival in patients presenting with primary disease.
| Variable | N | Distant recurrence, N | Median distant RFS, yr | 95 % CI | Log-rank P-value |
|---|---|---|---|---|---|
|
All pts |
70 |
29 |
2.48 |
(1.29, NA) |
|
|
Depth | |||||
| Superficial | 47 | 18 | 2.34 | (1.29, NA) | 0.834 |
| Deep |
14 |
5 |
NA |
(0.40, NA) |
|
|
Size | |||||
| ⩽5 cm | 40 | 17 | 2.34 | (0.99, NA) | 0.936 |
| >5 cm,⩽10 cm | 16 | 6 | NA | (1.31, NA) | |
| >10 cm |
11 |
3 |
NA |
(1.05, NA) |
|
|
Margin status | |||||
| R0 | 45 | 17 | 2.48 | (1.21, NA) | 0.0004 |
| R1 | 12 | 2 | NA | NA | |
| R2 |
8 |
6 |
0.49 |
(0.32, NA) |
|
|
Adjuvant Chemo | |||||
| No | 61 | 23 | 5.71 | (1.54, NA) | 0.291 |
| Yes | 9 | 6 | 1.05 | (0.65, NA) | |
Abbreviation: RFS=Recurrence free survival.